| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/09/2007 | CN1958606A Recombined composite epitope antigen of liver cancer, preparation method, and application of preparing medication for specific immunity treatment of liver cancer |
| 05/09/2007 | CN1958601A Quick separating and purifying protein 1 of singkwa fowelgourd |
| 05/09/2007 | CN1958074A Injectable block copolymer hydrogel of temperature sensibilityú¿epsi ¿C caprolactone - glycolideú®- polyethyleneglycol |
| 05/09/2007 | CN1958067A Composition of protective agent for radiation damage |
| 05/09/2007 | CN1958066A Spray agent for shielding ray in medical use |
| 05/09/2007 | CN1958065A Pidotimod capsule, and preparation |
| 05/09/2007 | CN1957925A Preparing Nano liposome of papain, and configuration control method |
| 05/09/2007 | CN1957920A Anti cancer controlled release agent of carried fluorouracil and synergist |
| 05/09/2007 | CN1957919A Controlled release agent of containing fluorouracil and synergist |
| 05/09/2007 | CN1957916A Anti cancer controlled release agent of carried interstitial hydrolytic agent and derivative of Epothilone |
| 05/09/2007 | CN1957915A Anti cancer controlled release agent of carried interstitial hydrolytic agent and medication of cell toxin |
| 05/09/2007 | CN1957914A Anti cancer controlled release agent of carried interstitial hydrolytic agent and medication of cell elements |
| 05/09/2007 | CN1957913A Composition of anti cancer medication prepared from carried platinum category compound and consubstantial hydrolytic agent |
| 05/09/2007 | CN1957912A Anti cancer controlled release formulation of containing interstitial hydrolytic agent |
| 05/09/2007 | CN1957911A Controlled release formulation for anti entity tumour |
| 05/09/2007 | CN1957910A Anti cancer controlled release formulation of containing consubstantial hydrolytic agent |
| 05/09/2007 | CN1314813C 虫草多肽制品及其制备方法和应用 Cordyceps polypeptide products and its preparation method and application |
| 05/09/2007 | CN1314807C Gene clone and expression of RGD die body protein of oral gland in Japan lamprey possessing function for anti tumour |
| 05/09/2007 | CN1314712C Preparation for fungus extracellular polysaccharide compound and application thereof |
| 05/09/2007 | CN1314705C Peptide for high performance inhibition of angiogenesis and method for preparing same and use thereof |
| 05/09/2007 | CN1314704C Oligopeptide suppressor of matrix metalloprotease 2 |
| 05/09/2007 | CN1314447C Method for preparing medicine with proteinase inhibiting function and its detecting method |
| 05/09/2007 | CN1314446C High-solidifiability fibrinogen gelatin |
| 05/09/2007 | CN1314445C Pulmonary administration of chemically modified insulin |
| 05/09/2007 | CN1314444C Medicinal composition for treating diabetes and its complication and viral hepatitis and its preparation method |
| 05/08/2007 | USRE39614 Canine IL-4 immunoregulatory proteins and uses thereof |
| 05/08/2007 | US7214790 Genes and proteins encoded thereby |
| 05/08/2007 | US7214785 isolating novel anti-FVIII inhibitor antibodies distinctly having specificity and the inhibitor activity to FVIII from lymphocytes of a patient by the antibody display phage technology and analyzed the VH and VL chains of said specific antibodies |
| 05/08/2007 | US7214782 Prognosis of neuroblastoma; antisense nucleic acids for malignant tumors |
| 05/08/2007 | US7214778 Solvent extraction from plant |
| 05/08/2007 | US7214774 Preparing and detecting antibodies by using the polypeptide as antigens, and selecting an antibody that specifically binds the polypeptide; developing drugs for the treatment of tumors. |
| 05/08/2007 | US7214772 Sialoadhesin family member-2 (SAF-2) |
| 05/08/2007 | US7214771 Nucleic acid and protein expression thereby and their involvement in stress |
| 05/08/2007 | US7214768 Echinocandin process |
| 05/08/2007 | US7214692 Medical use for tachykinin antagonists |
| 05/08/2007 | US7214663 The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide of three amino acids, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by a |
| 05/08/2007 | US7214662 Prevents the aggregation of LHRH antagonists in solutions; bioavailability |
| 05/08/2007 | US7214661 Methods of therapy with thrombin derived peptides |
| 05/08/2007 | US7214660 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety, for therapy |
| 05/08/2007 | US7214659 Use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing QTc interval |
| 05/08/2007 | US7214658 Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection |
| 05/08/2007 | US7214657 Method of transporting a chimeric hybrid molecule across the blood brain barrier |
| 05/08/2007 | US7214656 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents |
| 05/08/2007 | US7214655 Artificial tanning |
| 05/08/2007 | US7214654 Bone derived structural component, chemotactic component, adhesion component, and growth or maturation component on a polymer, ceramic, metallic or nonmetallic carrier; treating osteoporosis, psuedoarthrosis, and bone defects; filling large bone defects; healing endoprostheses; vertebral stabilization |
| 05/08/2007 | US7214533 Polynucleotide useful for modulating cancer cell proliferation |
| 05/08/2007 | US7214532 Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof |
| 05/08/2007 | US7214519 Identifying modulators associated with heme independent inhibition of soluble guanylyl cyclase for use in treatment of infection, hypertension and cardiovascular disorders |
| 05/08/2007 | US7214518 For therapy of diseases of cell proliferation |
| 05/08/2007 | US7214515 Viral delivery system for infectious transfer of large genomic DNA inserts |
| 05/08/2007 | US7214514 To produce human proteins in economical yields and in a form which is suitable for the production of a pharmaceutical preparation |
| 05/08/2007 | US7214512 Genomic mammary Amyloid a sequence |
| 05/08/2007 | US7214503 Adding a test compound to an in vitro mixture comprising a target protein complex that directly or indirectly produces ADP or phosphate, subjecting the mixture to an enzymatic reaction, determining the level of activity of the enzymatic reaction |
| 05/08/2007 | US7214499 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
| 05/08/2007 | US7214497 Viral encoded semaphorin protein receptor DNA and polypeptides |
| 05/08/2007 | US7214495 Screening method |
| 05/08/2007 | US7214482 Steroid-activated nuclear receptors and uses therefor |
| 05/08/2007 | US7214380 Composition of an allergen that causes Th2-type T cell response in a susceptible individual, Listeria adjuvant, and a pharmaceutically acceptable carrier; treating allergies associated with an established allergen specific Th2-type T cell response |
| 05/08/2007 | US7214376 Methods of inhibiting TNFα in patients with neoplastic disease |
| 05/08/2007 | US7214374 12832, a novel human kinase-like molecule and uses thereof |
| 05/08/2007 | US7214373 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 05/08/2007 | US7214369 applying pressure to mammalian skin around a limb using a sphygmomanometer and injecting a polynucleotide biodrug to promote angiogenesis |
| 05/08/2007 | US7214368 Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene |
| 05/08/2007 | US7214367 Orally-administered interferon-tau compositions and methods |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/08/2007 | CA2273824C Mutants of streptococcal toxin c and methods of use |
| 05/08/2007 | CA2185489C Cyclic adhesion inhibitors |
| 05/03/2007 | WO2007050866A2 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof |
| 05/03/2007 | WO2007050798A2 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer |
| 05/03/2007 | WO2007050661A2 C-reactive protein and its use to treat systemic lupus erythematosus and related conditions |
| 05/03/2007 | WO2007050651A1 Selective vpac2 receptor peptide agonists |
| 05/03/2007 | WO2007050581A2 An albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use |
| 05/03/2007 | WO2007050513A2 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity |
| 05/03/2007 | WO2007050319A1 In vivo detection of apoptosis |
| 05/03/2007 | WO2007050178A2 Skin care composition for accelerated production of collagen proteins and method of fabricating same |
| 05/03/2007 | WO2007050057A1 Identification, expression, functions and uses of mda-bf factors |
| 05/03/2007 | WO2007050043A2 Methods of specifying mesodermal, endodermal and mesoendodermal cell fates |
| 05/03/2007 | WO2007049941A1 Bioactive substance carrier for in vivo stable delivery tehreof, conjugate containing the same, and method of in vivo stable delivery of the bioactive substance |
| 05/03/2007 | WO2007049770A1 Outer coat protein pa5158 of pseudomonas aeruginosa |
| 05/03/2007 | WO2007049757A1 Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome |
| 05/03/2007 | WO2007049752A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
| 05/03/2007 | WO2007049749A1 Therapeutic method for blood coagulation disorder |
| 05/03/2007 | WO2007049695A1 Agglutinable glp-1 analogue and sustained-release pharmaceutical composition |
| 05/03/2007 | WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same |
| 05/03/2007 | WO2007049620A1 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor |
| 05/03/2007 | WO2007049424A1 Hepatic fibrosis inhibitor |
| 05/03/2007 | WO2007049400A1 Composition for promoting the production of collagen and/or hyaluronic acid |
| 05/03/2007 | WO2007049394A1 Peptides originating in hepatitis c virus |
| 05/03/2007 | WO2007049361A1 Liver fibrosis inhibitor |
| 05/03/2007 | WO2007049359A1 Method of controlling glucose metabolism |
| 05/03/2007 | WO2007049281A1 Ache polypeptides, polynucleotides encoding same and compositions and methods of using same |
| 05/03/2007 | WO2007049044A1 Siglec-9 binding agents |
| 05/03/2007 | WO2007048857A1 Use of tgf-$g(b)1 inhibitor peptides in the preparation of an immune response modulating agent |
| 05/03/2007 | WO2007048848A2 V-atpase inhibitors for use in the treatment of septic shock |
| 05/03/2007 | WO2007048413A1 IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF |
| 05/03/2007 | WO2007048357A1 Interferon-alpha and c-phycocyanin for the treatment of autoimmune diseases, allergic diseases and cancer |
| 05/03/2007 | WO2007048324A1 Bone morphogenetic protein-2-derived bioactive peptides and their preparing methods and uses |
| 05/03/2007 | WO2007048202A1 Methods and compositions for modulating wound repair |
| 05/03/2007 | WO2007030937A3 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |